NURIX THERAPEUTICS IN
22.00
08-10月-24 15:59:59
15 分の遅延
株式
+0.46
+2.14%
本日の幅
21.30 - 22.72
ISIN
N/A
ソース
NASDAQ
-
20 3 2024 09:40:00 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
11 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
06 3 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
05 3 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
15 2 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
01 2 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
16 1 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
08 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 1 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
07 11 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
02 11 2023 09:00:01 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics Announces Partial Clinical Hold For NX-2127 Phase 1 Trial
01 11 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
12 10 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
31 8 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
13 7 2023 16:01:00 提供 Nasdaq GlobeNewswire